Status:
COMPLETED
Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Sumitomo Pharma America, Inc.
Beth Israel Deaconess Medical Center
Conditions:
Schizophrenia
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
This study will determine whether eszopiclone will normalize sleep patterns and restore sleep-dependent enhancement of motor skill learning in patients with schizophrenia. The investigators will compa...
Eligibility Criteria
Inclusion
- Clinically stable outpatients with DSM-IV diagnoses of Schizophrenia
Exclusion
- History of neurologic or psychiatric disease other than schizophrenia
- Substance abuse or dependence within the past six months
- Other chronic medical conditions that affect sleep
- Pregnancy/breast feeding
- Hepatic impairment
- Treatment with metabolic inhibitors or inducers
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00833547
Start Date
September 1 2006
End Date
September 1 2012
Last Update
September 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mass General Hospital
Boston, Massachusetts, United States, 02114